Related Experiment Videos
The seventies evolution in liver surgery for cancer
Cancer
|May 1, 1981
Summary
Surgical advancements have improved liver cancer treatment, increasing resectability rates and patient survival. Staging liver disease helps select patients who benefit most from surgery, offering a potential cure with minimal risk.
Area of Science:
- Oncology
- Surgical Oncology
- Hepatobiliary Surgery
Background:
- Significant evolution in surgical approaches for primary and secondary liver cancer over the last decade.
- Advancements in liver transplantation and vascular surgery principles have enhanced resectability rates.
Purpose of the Study:
- To evaluate the impact of modern surgical techniques on liver cancer treatment outcomes.
- To assess the efficacy of surgical resection for primary and metastatic liver tumors.
- To establish staging criteria for better patient selection and outcome prediction.
Main Methods:
- Analysis of outcomes for 436 patients treated for liver tumors over a decade.
- Application of advanced intraoperative and postoperative support measures.
- Kaplan-Meier survival analysis based on disease staging (Stage I, II, III).
Main Results:
- Achieved a 32% resectability rate with a 9% 30-day operative mortality.
- Median operating time reduced to 4 3/4 hours with minimal complications and a 13-day median postoperative hospital stay.
- Stage I disease demonstrated 85% (primary) and 71% (metastatic colorectal) three-year survival; Stages II/III showed significantly lower survival rates.
Conclusions:
- Surgery offers a curative option for an increasing number of patients with liver cancer, including metastatic disease.
- Disease staging is crucial for identifying patients likely to benefit from surgical intervention.
- Adjuvant chemotherapy may further improve survival rates in select patients.